Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Natural inspired ligustrazine-based SLC-0111 analogues as novel carbonic anhydrase inhibitors
Diaaeldin M. Elimam, Wagdy M. Eldehna, Rofaida Salem, et al.
European Journal of Medicinal Chemistry (2021) Vol. 228, pp. 114008-114008
Closed Access | Times Cited: 17

Showing 17 citing articles:

Targeting carbonic anhydrase IX and XII isoforms with small molecule inhibitors and monoclonal antibodies
Mateusz Kciuk, Adrianna Gielecińska, Somdutt Mujwar, et al.
Journal of Enzyme Inhibition and Medicinal Chemistry (2022) Vol. 37, Iss. 1, pp. 1278-1298
Open Access | Times Cited: 69
Discovery and Mechanistic Studies of Dual-Target Hits for Carbonic Anhydrase IX and VEGFR-2 as Potential Agents for Solid Tumors: X-ray, In Vitro, In Vivo, and In Silico Investigations of Coumarin-Based Thiazoles
Salma M. Hefny, Tarek F. El‐Moselhy, Nabaweya Sharaf El-Din, et al.
Journal of Medicinal Chemistry (2024) Vol. 67, Iss. 9, pp. 7406-7430
Closed Access | Times Cited: 8
Novel N-(3-(1-(4-sulfamoylphenyl)triazol-4-yl)phenyl)benzamide Derivatives as Potent Carbonic Anhydrase Inhibitors with Broad-Spectrum Anticancer Activity: Leveraging Tail and Dual-Tail Approaches
Ashraf K. El‐Damasy, Hyun Ji Kim, Muhammad Faisal, et al.
Journal of Medicinal Chemistry (2025)
Closed Access
Design and synthesis of benzothiazole-based SLC-0111 analogues as new inhibitors for the cancer-associated carbonic anhydrase isoforms IX and XII
Tarfah Al‐Warhi, Mostafa M. Elbadawi, Alessandro Bonardi, et al.
Journal of Enzyme Inhibition and Medicinal Chemistry (2022) Vol. 37, Iss. 1, pp. 2635-2643
Open Access | Times Cited: 32
Design and synthesis of 6-arylpyridine-tethered sulfonamides as novel selective inhibitors of carbonic anhydrase IX with promising antitumor features toward the human colorectal cancer
Wagdy M. Eldehna, Eslam Essam Mohammed, Ghada H. Al-Ansary, et al.
European Journal of Medicinal Chemistry (2023) Vol. 258, pp. 115538-115538
Closed Access | Times Cited: 17
Targeting carbonic anhydrases for the management of hypoxic metastatic tumors
Claudiu T. Supuran
Expert Opinion on Therapeutic Patents (2023) Vol. 33, Iss. 11, pp. 701-720
Closed Access | Times Cited: 17
Ligustrazine as a multitarget scaffold in drug design and discovery
Xueyang Jiang, Siyi Li, Ning Wang, et al.
Bioorganic & Medicinal Chemistry (2025) Vol. 121, pp. 118110-118110
Closed Access
Discovery of new 6-ureido/amidocoumarins as highly potent and selective inhibitors for the tumour-relevant carbonic anhydrases IX and XII
Ashraf K. El‐Damasy, Hyun Ji Kim, Alessio Nocentini, et al.
Journal of Enzyme Inhibition and Medicinal Chemistry (2023) Vol. 38, Iss. 1
Open Access | Times Cited: 13
Synthesis and anticancer activity of new benzensulfonamides incorporating s-triazines as cyclic linkers for inhibition of carbonic anhydrase IX
Abdelrahman I. Zain-Alabdeen, Tarek F. El‐Moselhy, Nabaweya Sharafeldin, et al.
Scientific Reports (2022) Vol. 12, Iss. 1
Open Access | Times Cited: 19
Isosteviol – A new scaffold for the synthesis of carbonic anhydrase II inhibitors
Toni C. Denner, Niels V. Heise, René Csük
Results in Chemistry (2024) Vol. 7, pp. 101426-101426
Open Access | Times Cited: 3
Interactions of novel 1,3-diaryltriazene-sulfamethazines with carbonic anhydrases: Kinetic studies and in silico simulations
Nebih Lolak, Cüneyt Türkeş, Süleyman Akocak, et al.
Archives of Biochemistry and Biophysics (2024) Vol. 761, pp. 110181-110181
Closed Access | Times Cited: 3
Insights into the effect of elaborating coumarin-based aryl enaminones with sulfonamide or carboxylic acid functionality on carbonic anhydrase inhibitory potency and selectivity
Hany S. Ibrahim, Mohamed A. Abdelrahman, Alessio Nocentini, et al.
Bioorganic Chemistry (2022) Vol. 126, pp. 105888-105888
Closed Access | Times Cited: 17
Novel Anthraquinone-Based Benzenesulfonamide Derivatives and Their Analogues as Potent Human Carbonic Anhydrase Inhibitors with Antitumor Activity: Synthesis, Biological Evaluation, and In Silico Analysis
Shanshan Wu, Xiaoping Zhou, Fei Li, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 6, pp. 3348-3348
Open Access | Times Cited: 2
Novel 1,2,4-triazoles as selective carbonic anhydrase inhibitors showing ancillary anticathepsin B activity
Amit Kumar, Priyanka Arya, Simone Giovannuzzi, et al.
Future Medicinal Chemistry (2024) Vol. 16, Iss. 8, pp. 689-706
Closed Access | Times Cited: 2
Synthesis, biological evaluation and in silico studies of novel thiadiazole-hydrazone derivatives for carbonic anhydrase inhibitory and anticancer activities
Hayrani Eren Bostancı, Ulviye Acar Çevik, Ravikumar Kapavarapu, et al.
SAR and QSAR in environmental research (2023) Vol. 34, Iss. 7, pp. 543-567
Open Access | Times Cited: 7
Enaminone-based carboxylic acids as novel non-classical carbonic anhydrases inhibitors: design, synthesis and in vitro biological assessment
Mahmoud F. Abo-Ashour, Hadia Almahli, Alessandro Bonardi, et al.
Journal of Enzyme Inhibition and Medicinal Chemistry (2022) Vol. 37, Iss. 1, pp. 2256-2264
Open Access | Times Cited: 9
Synthesis, Anticancer Activity and Carbonic Anhydrase Inhibitory Activity of new Thiadiazole-hydrazone Derivatives
Hayrani Eren Bostancı, Ulviye Acar Çevik
Cumhuriyet Science Journal (2023) Vol. 44, Iss. 2, pp. 258-262
Open Access
Page 1

Scroll to top